Home » Newsletters » BioWorld Asia

BioWorld Asia

March 22, 2000

View Archived Issues

Other News To Note

GPC's Acquisition Of Mitotix Sees Transatlantic Firm Formed

More European Industry Attempts To Counter Anti-GM Prejudice

International Geneticists Identify Gene Causing Rare Dwarfism

Morphochem Acquires U.S.-Based Drug Screening Assay Developer

Genset Issues $10M In Shares To Abbott Laboratories

Vanguard, Wolfson Institute Expand Collaboration On CNS Treatments

Start-up Firm Files Patents On Gene-Profiling System

Promix Receives Venture Funds For Push In Rheumatoid Arthritis Area

Antisoma Prepares To Move Therex Into Phase IIa Breast Cancer Trials

NicOx Starts Phase I/II Trial Of Its Dermatology Drug

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...